Spinal metastasis in thyroid cancer

[1]  Meic H. Schmidt,et al.  Cervical spine metastases: techniques for anterior reconstruction and stabilization , 2012, Neurosurgical Review.

[2]  F. Bonichon,et al.  Multidisciplinary treatment and survival of patients with vertebral metastases from thyroid carcinoma. , 2012, Thyroid : official journal of the American Thyroid Association.

[3]  E. Baudin,et al.  Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Wexler.  Approach to the thyroid cancer patient with bone metastases. , 2011, The Journal of clinical endocrinology and metabolism.

[5]  Quan-Yong Luo,et al.  Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. , 2011, The Journal of clinical endocrinology and metabolism.

[6]  H. Tsuchiya,et al.  Total en bloc spondylectomy for spinal metastases in thyroid carcinoma. , 2011, Journal of neurosurgery. Spine.

[7]  S. Devesa,et al.  Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. , 2011, Thyroid : official journal of the American Thyroid Association.

[8]  J. Manabe,et al.  Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma. , 2011, Thyroid : official journal of the American Thyroid Association.

[9]  R. Harel,et al.  Spine metastases: current treatments and future directions. , 2010, European journal of cancer.

[10]  Ziya L Gokaslan,et al.  Diagnosis and management of metastatic spine disease. A review. , 2010, Journal of neurosurgery. Spine.

[11]  Khoi D. Than,et al.  Solitary spinal metastasis of Hürthle cell thyroid carcinoma , 2010, Journal of Clinical Neuroscience.

[12]  Michelle D. Williams,et al.  Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. , 2010, The Journal of clinical endocrinology and metabolism.

[13]  N. Theodore,et al.  Percutaneous vertebroplasty for thyroid cancer metastases to the spine. , 2010, Thyroid : official journal of the American Thyroid Association.

[14]  I. Sugitani,et al.  Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. , 2010, Surgery.

[15]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[16]  Nathaniel Rothman,et al.  International patterns and trends in thyroid cancer incidence, 1973–2002 , 2009, Cancer Causes & Control.

[17]  Jiachao Liang,et al.  Phase II trial of sorafenib in metastatic thyroid cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Gravendeel,et al.  Embolization therapy of bone metastases from epithelial thyroid carcinoma: effect on symptoms and serum thyroglobulin. , 2008, Thyroid : official journal of the American Thyroid Association.

[19]  R. Zarnegar,et al.  Bone metastases from differentiated thyroid carcinoma. , 2008, Endocrine-related cancer.

[20]  M. Rajer,et al.  Malignant spinal cord compression , 2008 .

[21]  E. Hindié,et al.  Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome. , 2007, Endocrine-related cancer.

[22]  Jennings R. Boyette,et al.  Bisphosphonates and jaw osteonecrosis: The UAMS experience , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[23]  E. Baudin,et al.  New therapeutic approaches for metastatic thyroid carcinoma. , 2007, The Lancet. Oncology.

[24]  Jonathan N Grauer,et al.  Metastatic Disease of the Spine , 2006, The Journal of the American Academy of Orthopaedic Surgeons.

[25]  Gerard M Doherty,et al.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.

[26]  H. Yoshikawa,et al.  Prognostic Relevance of Clinical Symptoms in Patients with Spinal Metastases , 2005, Clinical orthopaedics and related research.

[27]  C. Bucana,et al.  Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular growth factor receptor phosphorylation. , 2005, Cancer research.

[28]  J. Brierley,et al.  The management of advanced thyroid cancer. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

[29]  A. Laxton,et al.  Metastatic spine disease: epidemiology, pathophysiology, and evaluation of patients. , 2004, Neurosurgery clinics of North America.

[30]  G. Roodman.  Mechanisms of bone metastasis. , 2004, Discovery medicine.

[31]  J. Wass,et al.  Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour. , 2004, Endocrine-related cancer.

[32]  J. Romijn,et al.  Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.

[33]  J. Shah,et al.  The role of operations for distantly metastatic well-differentiated thyroid carcinoma. , 2002, Surgery.

[34]  G. Zettinig,et al.  Long‐term follow‐up of patients with bone metastases from differentiated thyroid carcinoma – surgery or conventional therapy? , 2002, Clinical endocrinology.

[35]  A. Abbruzzese,et al.  Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer , 2001, British Journal of Cancer.

[36]  G. Hejblum,et al.  Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. , 2001, The Journal of clinical endocrinology and metabolism.

[37]  T. Petrich,et al.  Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age , 2001, European Journal of Nuclear Medicine.

[38]  S. Larson,et al.  Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates. , 2000, Archives of pathology & laboratory medicine.

[39]  R. Dullaart,et al.  Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma , 2000, Clinical endocrinology.

[40]  P. Schultz,et al.  Differentiated thyroid cancer in children and adolescents: Clinical outcome and mortality after long‐term follow‐up , 1998, Head & neck.

[41]  M. Schlumberger,et al.  Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[43]  W. H. Thomas,et al.  Distant metastases from mixed tumors of the salivary glands , 1965, American journal of surgery.

[44]  O. V. Batson.  THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES , 1940, Annals of surgery.

[45]  Z. Gokaslan,et al.  Diagnosis and management of metastatic cervical spine tumors. , 2012, The Orthopedic clinics of North America.

[46]  J. Palussiere,et al.  [Management of painful bone metastases]. , 2011, Journal de radiologie.

[47]  Y. Tokuhashi,et al.  Algorithms and planning in metastatic spine tumors. , 2009, The Orthopedic clinics of North America.

[48]  E. Baudin,et al.  Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. , 2006, The Journal of clinical endocrinology and metabolism.

[49]  S. Sherman.  The Management of Metastatic Differentiated Thyroid Carcinoma , 2004, Reviews in Endocrine and Metabolic Disorders.

[50]  S. Larson,et al.  Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. , 2000, Thyroid : official journal of the American Thyroid Association.

[51]  J. Olson,et al.  Thyroid carcinoma. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[52]  L. Einhorn,et al.  Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial. , 1986, Cancer treatment reports.